{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:48:43Z","timestamp":1783385323055,"version":"3.54.6"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.ijcard.2016.11.031","type":"journal-article","created":{"date-parts":[[2016,11,14]],"date-time":"2016-11-14T13:30:22Z","timestamp":1479130222000},"page":"563-569","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Superior long term outcome associated with native vessel versus graft vessel PCI following secondary PCI in patients with prior CABG"],"prefix":"10.1016","volume":"228","author":[{"given":"Chrysostomos A.","family":"Mavroudis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tushar","family":"Kotecha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Chehab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Hudson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roby D.","family":"Rakhit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2016.11.031_bb0005","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1093\/eurheartj\/ehq277","volume":"31","year":"2010","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2016.11.031_bb0010","doi-asserted-by":"crossref","first-page":"528","DOI":"10.7326\/0003-4819-123-7-199510010-00009","article-title":"Coronary artery bypass graft disease","volume":"123","author":"Nwasokwa","year":"1995","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ijcard.2016.11.031_bb0015","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/0735-1097(96)00206-9","article-title":"Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25years","volume":"28","author":"Fitzgibbon","year":"1996","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2016.11.031_bb0020","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1161\/01.CIR.97.9.916","article-title":"Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention","volume":"97","author":"Motwani","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.11.031_bb0025","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/S0735-1097(03)01039-8","article-title":"Percutaneous treatment of saphenous vein graft disease: the ongoing challenge","volume":"42","author":"Baim","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2016.11.031_bb0030","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1001\/jama.294.19.2446","article-title":"PREVENT IV Investigators. Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial","volume":"294","author":"Alexander","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2016.11.031_bb0035","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1016\/S0735-1097(02)02560-3","article-title":"Percutaneous coronary intervention versus repeat bypass surgery for patients with medically refractory myocardial ischemia: AWESOME randomized trial and registry experience with post-CABG patients","volume":"40","author":"Morrison","year":"2002","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.11.031_bb0040","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/ccd.20498","article-title":"Drug-eluting stenting is superior to bare metal stenting in saphenous vein grafts","volume":"66","author":"Lee","year":"2005","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"10.1016\/j.ijcard.2016.11.031_bb0045","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.amjcard.2005.08.018","article-title":"Efficacy of sirolimus-eluting stents compared with bare metal stents for saphenous vein graft intervention","volume":"97","author":"Chu","year":"2006","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.11.031_bb0050","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1540-8183.2007.00301.x","article-title":"Long-term clinical benefit of sirolimus-eluting stents compared to bare metal stents in the treatment of saphenous vein graft disease","volume":"20","author":"Minutello","year":"2007","journal-title":"J. Interv. Cardiol."},{"key":"10.1016\/j.ijcard.2016.11.031_bb0055","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s00392-006-0460-1","article-title":"Comparison of the slow-release polymerbased paclitaxel-eluting Taxus-Express stent with the bare-metal Express stent for saphenous vein graft interventions","volume":"96","author":"Wohrle","year":"2007","journal-title":"Clin. Res. Cardiol."},{"key":"10.1016\/j.ijcard.2016.11.031_bb0060","first-page":"404","article-title":"Utility of sirolimus-eluting Cypher stents to reduce 12-month target vessel revascularization in saphenous vein graft stenoses: results of a multicenter 350-patient case-control study","volume":"19","author":"Ellis","year":"2007","journal-title":"J. Invasive Cardiol."},{"key":"10.1016\/j.ijcard.2016.11.031_bb0065","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.amjcard.2007.11.055","article-title":"A. Long-term outcomes with drug-eluting stents versus bare metal stents in the treatment of saphenous vein graft disease (results from the REgistroRegionaleAngiopLastiche Emilia-Romagna Registry)","volume":"101","author":"Vignali","year":"2008","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.11.031_bb0070","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1080\/17482940701885400","article-title":"Immediate procedural and long-term clinical outcomes following drug-eluting stent implantation to ostial saphenous vein graft lesions","volume":"10","author":"Kaplan","year":"2008","journal-title":"Acute Card. Care"},{"key":"10.1016\/j.ijcard.2016.11.031_bb0075","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/ccd.21566","article-title":"Late outcomes of drug-eluting versus bare metal stents in saphenous vein grafts: propensity score analysis","volume":"72","author":"Applegate","year":"2008","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"10.1016\/j.ijcard.2016.11.031_bb0080","doi-asserted-by":"crossref","first-page":"108","DOI":"10.4244\/EIJV4I1A18","article-title":"Beneficial 2-years results of drug-eluting stents in saphenous vein graft lesions","volume":"4","author":"Assali","year":"2008","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ijcard.2016.11.031_bb0085","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.amjcard.2008.04.041","article-title":"R. Drug-eluting stents versus bare metal stents for narrowing in saphenous vein grafts","volume":"102","author":"Okabe","year":"2008","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.11.031_bb0090","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000137699","article-title":"BASKET Investigators. Drug-eluting stents compared with bare metal stents improve late outcome after saphenous vein graft but not after large native vessel interventions","volume":"112","author":"Jeger","year":"2009","journal-title":"Cardiology"},{"key":"10.1016\/j.ijcard.2016.11.031_bb0095","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1016\/j.jacc.2006.09.021","article-title":"Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC Trial","volume":"48","author":"Vermeersch","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2016.11.031_bb0100","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.jacc.2008.11.029","article-title":"A randomized controlled trial of a paclitaxel-eluting stent versus a similar bare-metal stent in saphenous vein graft lesions the SOS (Stenting of Saphenous Vein Grafts) trial","volume":"53","author":"Brilakis","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcard.2016.11.031_bb0105","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jcin.2010.10.003","article-title":"Continued Benefit From Paclitaxel-Eluting Compared With Bare-Metal Stent Implantation in Saphenous Vein Graft Lesions During Long-Term Follow-Up of the SOS (Stenting of Saphenous Vein Grafts) Trial","volume":"4","author":"Brilakis","year":"2011","journal-title":"J. Am. Coll. Cardiol. Intv."},{"key":"10.1016\/j.ijcard.2016.11.031_bb0110","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.amjcard.2007.02.052","article-title":"Intravascular ultrasound comparison of sirolimus-eluting stent versus bare metal stent implantation in diseased saphenous vein grafts (from the RRISC [Reduction of Restenosis In Saphenous Vein Grafts With Cypher Sirolimus-Eluting Stent] trial)","volume":"100","author":"Agostoni","year":"2007","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.11.031_bb0115","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1161\/CIRCULATIONAHA.106.651232","article-title":"Graft Stenting and Major Adverse Cardiac Events. A Predictive Model Derived From a Pooled Analysis of 3958 Patients","volume":"117","author":"Coolong","year":"2008","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.ijcard.2016.11.031_bb0120","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jcin.2011.03.018","article-title":"Percutaneous Coronary Intervention in Native Arteries Versus Bypass Grafts in Prior Coronary Artery Bypass Grafting Patients. A Report From the National Cardiovascular Data Registry","volume":"4","author":"Brilakis","year":"2011","journal-title":"J. Am. Coll. Cardiol. Intv."},{"key":"10.1016\/j.ijcard.2016.11.031_bb0125","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.carrev.2008.12.002","article-title":"Comparison of percutaneous coronary intervention in native coronary arteries vs. bypass grafts in patients with prior coronary artery bypass graft surgery","volume":"10","author":"Varghese","year":"2009","journal-title":"Cardiovasc. Revasc. Med."},{"key":"10.1016\/j.ijcard.2016.11.031_bb0130","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0735-1097(01)01420-6","article-title":"Long-term clinical outcome and predictors of major adverse cardiac events after percutaneous interventions on saphenous vein grafts","volume":"38","author":"Keeley","year":"2001","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316334775?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316334775?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T04:45:54Z","timestamp":1552970754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527316334775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":26,"alternative-id":["S0167527316334775"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.11.031","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Superior long term outcome associated with native vessel versus graft vessel PCI following secondary PCI in patients with prior CABG","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.11.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}